TARO TO INTRODUCE ONE DOZEN "NICHE" OTCs BY END OF 1994
This article was originally published in The Tan Sheet
Executive Summary
TARO TO INTRODUCE ONE DOZEN "NICHE" OTCs BY END OF 1994 in the U.S. and Canada that will be imported from the firm's manufacturing facilities in Israel, Taro Senior VP and Chief Operating Officer Peter Giallorenzo told analysts at the recent Kidder, Peabody Healthcare Conference in New York City. Taro said the majority of the OTCs will be marketed in the cough/cold and analgesic categories in both topical and liquid forms. To date, the company's primary focus has been on products in the dermatologic category.